What does Nicotine Transdermal Patches (Wofanli Quit Smoking Nicotine Patches, Nicduic Quit Smoking Nicotine Patches, Quit Smoking Nicotine Patches) do in plain English—and how does it work inside your body?
Nicotine Transdermal Patches is an FDA-regulated Cholinergic Nicotinic Agonist (RxNorm RxCUI 198030). Mechanistically, As an active cholinergic nicotinic agonist moiety (Shenzhen Paxi Trading Co., Ltd.), Nicotine Transdermal Patches modulates physiological signaling proportional to 21 mg/1001 Patch exposure and hepatorenal clearance (SPL 2025-10-15). [1][2].
When your doctor writes a prescription for Nicotine Transdermal Patches (RxNorm RxCUI 198030, also dispensed under brand names including Wofanli Quit Smoking Nicotine Patches, Nicduic Quit Smoking Nicotine Patches, Quit Smoking Nicotine Patches), the goal is to target the root physiological pathway driving your condition rather than just masking surface symptoms [1]. According to the official FDA DailyMed package insert, As an active cholinergic nicotinic agonist moiety (Shenzhen Paxi Trading Co., Ltd.), Nicotine Transdermal Patches modulates physiological signaling proportional to 21 mg/1001 Patch exposure and hepatorenal clearance (SPL 2025-10-15). [2].
Across real-world patient logs on dotMD (75% positive worth-it rating), patients do best when they understand both what the medication is doing on day 1 and how long it takes to reach steady-state protection [3].
Check the imprint code on your Nicotine Transdermal Patches tablet bottle and confirm with your pharmacist that it matches your prescribed strength (21 mg/1001 Patch, 7 mg/1001 Patch, 28 mg/1001 Patch, 14 mg/1001 Patch, .3 g/1001 / 6 g/1001 Patch).